Abstract: The present invention relates to a pharmaceutical composition for preventing or treating dry eye, containing a compound represented by a formula I, an optical isomer thereof or a pharmaceutically acceptable salt thereof as an effective component, as well as a treatment method using the compound, and use of the compound in the manufacture of a medicament for treating dry eye. The pharmaceutical composition according to the present invention shows an excellent effect of preventing or treating dry eye.

Abstract: The present invention relates to a pharmaceutical composition for preventing or treating uveitis, containing a compound represented by a formula I, an optical isomer thereof or a pharmaceutically acceptable salt thereof as an effective component, as well as a treatment method using the compound, and use of the compound in the manufacture of a medicament for treating uveitis. The pharmaceutical composition according to the present invention shows an excellent effect of preventing or treating uveitis.

Abstract: The present invention relates to a coated particle of amlodipine maleate and a pharmaceutical composition for cardiovascular disease (CVD) comprising the coated particle of amlodipine maleate. The pharmaceutical composition of the present invention has stable bioavailability due to sufficient dissolution rate and prevents decomposition reaction of amlodipine to thereby being formulated with formulation-stability equal to or higher than amlodipine besylate under long storage.